Skip to main content
Signal8
Launch Terminal

NOMAD POWER SOLUTIONS, INC. (NMAD)

NOMAD Power Solutions, Inc., through its wholly owned subsidiary NOMAD Transportable Power Systems, provides transportable, utility-grade battery energy storage systems. The company's mobile battery energy storage system (BESS) platforms deliver rapidly deployable, scalable energy solutions for electric utilities, data centers, commercial and industrial customers, emergency response, renewable energy integration, and grid modernization. The company also continues to advance a life sciences portfolio, including the development of novel oncology therapeutics.

Sector: Pharmaceutical Preparations

Industry: Biotechnology

NOMAD Power Solutions, Inc. logo

NOMAD Power Solutions, Inc.

NASDAQ:NMADHealthcare
+0.56%$3.56
AH$3.50-1.69%vs close
Mkt Cap-
Float2.77M
O/S-
Vol
$ Vol
RVOL
Inst Own10.1%
Earnings
Dilution
NOMAD Power Solutions, Inc. logoNASDAQ:NMAD$3.56+0.56%
Pipeline2 lead-sponsored trials·1 active1 completed(1 more as collaborator)

Trials need funding. See this company's dilution risk and cash position.

Clinical Trials
Sponsor role
Status
Phase
  • Phase 1/2
    Recruiting

    A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)

    LB-100

    Myelodysplastic Syndromes

    Enrollment
    47
    Start
    Apr 2019est.
    Primary Completion
    May 2021est.
    Completion
    Jul 2021est.
    NCT03886662
  • Phase 1
    Completed

    Phase I Study of LB-100 With Docetaxel in Solid Tumors

    LB-100 for Injection, Docetaxel

    Tumors, Neoplasms +1

    Enrollment
    29
    Start
    Feb 2013
    Primary Completion
    Sep 2016
    Completion
    Sep 2016
    NCT01837667
Search ClinicalTrials.gov for “Nomad Power Solutions”